Top compounds associated with response to C1orf27


Feature Type Standardized
Nominal ANOVA
mRNA YM201636 GDSC1000 pan-cancer AAC 0.094 0.002
mRNA BIBW2992 CTRPv2 pan-cancer AAC 0.12 0.002
mRNA lapatinib gCSI pan-cancer AAC 0.16 0.003
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 0.003
mRNA Erlotinib gCSI pan-cancer AAC 0.16 0.003
mRNA BMS-754807 GDSC1000 pan-cancer AAC 0.097 0.003
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.004
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.004
mRNA BRD-K44224150 CTRPv2 pan-cancer AAC -0.23 0.004
mRNA QL-XII-47 GDSC1000 pan-cancer AAC 0.093 0.004
Download CSV